2004
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities
Garfein R, Monterroso E, Tong T, Vlahov D, Des Jarlais D, Selwyn P, Kerndt P, Word C, Fernando M, Ouellet L, Holmberg S. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. Journal Of Urban Health 2004, 81: 260-267. PMID: 15136659, PMCID: PMC3456450, DOI: 10.1093/jurban/jth112.Peer-Reviewed Original ResearchConceptsInjection drug usersRisk behaviorsHIV seroprevalenceHigh human immunodeficiency virus (HIV) seroprevalenceDrug usersHIV infection risk behaviorsHuman immunodeficiency virus (HIV) seroprevalenceInfection risk behaviorsPotential risk factorsHIV risk behaviorsHIV incidenceHIV statusRisk factorsVirus seroprevalenceSexual partnersPrevention effortsSeroprevalenceBaseline dataHIVFace interviewsInjectionNew York CityFurther effortsNew HavenParticipants
2003
Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort
Bernstein K, Jacobson L, Jenkins F, Vlahov D, Armenian H. Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort. Sexually Transmitted Diseases 2003, 30: 199-204. PMID: 12616135, DOI: 10.1097/00007435-200303000-00004.Peer-Reviewed Original ResearchConceptsHHV-8 seroprevalenceRisk factorsHHV-8Human herpesvirus type 8 infectionLarger body mass indexHuman herpesvirus type 8Drug user cohortHHV-8 seropositivityInjection drug useBody mass indexMultivariate logistic regressionCross-sectional studyDrug user populationGenital wartsMass indexGeneral populationDrug useSeroprevalenceIndirect immunofluorescenceLogistic regressionIDUsInfectionType 8User cohortSexual behavior
2002
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program
Vertefeuille J, Strathdee S, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program. Journal Of Drug Issues 2002, 32: 1125-1138. DOI: 10.1177/002204260203200408.Peer-Reviewed Original ResearchInjection drug usersHIV seroprevalenceHIV-seronegative counterpartsHIV-seropositive individualsHIV risk factorsDaily cocaine injectionsDaily heroin injectionDrug use characteristicsHarms of drugsHIV seropositive statusNeedle exchange programsLogistic regression modelsSpeedball injectionHIV antibodiesHIV infectionHeroin injectionProspective studyRisk factorsCocaine injectionFactors AssociatedDrug usersMultivariate modelProgram entryHIVSeroprevalence
1994
Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV
Behrendt C, Kendig N, Dambita C, Horman J, Lowlor J, Vlahov D. Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV. American Journal Of Epidemiology 1994, 139: 918-926. PMID: 8166142, DOI: 10.1093/oxfordjournals.aje.a117098.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV-seropositive inmatesVoluntary testingHIV seroprevalenceImmunodeficiency virusCurrent syphilis infectionHigh HIV seroprevalenceSimilar risk factorsMandatory HIV testingSyphilis infectionHIV infectionHIV serosurveyHIV testingRisk factorsHigh prevalencePrison entrantsLower riskPrison populationHigh-risk inmatesDrug useSimilar screeningRisk inmatesSeroprevalenceSerosurveyInfectionThe trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson K. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal Of Public Health 1994, 84: 382-7. PMID: 8129052, PMCID: PMC1614821, DOI: 10.2105/ajph.84.3.382.Peer-Reviewed Original ResearchConceptsFemale intravenous drug usersIntravenous drug usersHIV seropositivityHIV infectionDrug usersHuman immunodeficiency virus (HIV) seroprevalenceIntravenous drug useDrug-using womenTrading of sexCohort studyVirus seroprevalenceDrug useCocaine useIntensive interventionLogistic regressionSeropositivityNumber of partnersMultivariate modelDrugsWomenSexInfectionGroupHigh levelsSeroprevalenceEpidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions
Levine O, Vlahov D, Nelson K. Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions. Epidemiologic Reviews 1994, 16: 418-436. PMID: 7713187, DOI: 10.1093/oxfordjournals.epirev.a036161.Peer-Reviewed Original Research
1991
Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users
Nelson K, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony J. Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users. JAMA 1991, 266: 2259-2261. PMID: 1920726, DOI: 10.1001/jama.1991.03470160091038.Peer-Reviewed Original ResearchConceptsHistory of diabetesIntravenous drug usersDrug usersHIV seroprevalenceDrug useHuman immunodeficiency virus (HIV) seroprevalenceHuman immunodeficiency virus (HIV) infectionLow HIV seroprevalenceImmunodeficiency virus infectionSafe injection practicesApparent protective effectSterile injection equipmentCross-sectional surveyHIV infectionStudy clinicInjection paraphernaliaVirus seroprevalenceVirus infectionDrug treatmentProtective effectInjection practicesDiabetesPast monthSeroprevalenceSimilar durationPrevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities
1990
ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND
VLAHOV D, MUñOZ A, ANTHONY J, COHN S, CELENTANO D, NELSON K. ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND. American Journal Of Epidemiology 1990, 132: 847-856. PMID: 2239899, DOI: 10.1093/oxfordjournals.aje.a115727.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 seroprevalenceVirus type 1Drug usersInjection careerShooting galleriesType 1Drug injection patternsHIV-1 serostatusHIV-1 infectionRecent onsetDrug injectionHigh riskCommunity outreach effortsDrug useGallery useSame calendar yearSex practicesSeroprevalenceCalendar yearPersistent useAntibodiesPersistent sharingBlood and Plasma Donations Among a Cohort of Intravenous Drug Users
Nelson K, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. JAMA 1990, 263: 2194-2197. PMID: 1969502, DOI: 10.1001/jama.1990.03440160056037.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seroprevalenceIntravenous drug useDrug usersHuman immunodeficiency virus serologic statusDrug useHIV test resultsCD4 lymphocytesEntire cohortPeripheral bloodSerologic statusDonor poolIntravenous drugsHIV-1Blood donationMost subjectsPlasma donationBloodCohortDonation historySeroprevalenceDonationLymphocytesHistoryPlasmaSeasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons
Vlahov D, Muñoz A, Brewer F, Taylor E, Canner C, Polk B. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons. AIDS 1990, 4: 345-350. PMID: 2350455, DOI: 10.1097/00002030-199004000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultBlack or African AmericanDistrict of ColumbiaForecastingHealth Planning OrganizationsHispanic or LatinoHIV AntibodiesHIV SeropositivityHIV SeroprevalenceHumansMaleMarylandMultivariate AnalysisPeriodicityPrisonersSeasonsState Health Planning and Development AgenciesSubstance Abuse, IntravenousUnited StatesConceptsIncoming male inmatesHIV-1HIV-1 seroprevalenceHIV-1 infectionEnzyme-linked immunosorbentMultivariate adjustmentPrevious serosurveysSignificant changesBlack raceMale inmatesPrison entrantsMultivariate analysisExcess serumMaryland prisonsWestern blotSeroprevalenceStudy periodAntibodiesDemographic variablesAgeSubgroups